Delayed hemolytic transfusion reaction due to anti-Jsa in an alloimmunized patient with a sickle cell syndrome

American Journal of Clinical Pathology

Volumn 108, Issue 6, 1997, Pages 658-661

  Anderson, Richard R ^a   Sosler, Steven D ^a   Kovach, Janice ^a   DeChristopher, Phillip J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alloimmunization; Anti Jsa; Sickle cell; Transfusion reaction

Indexed keywords

HEMOGLOBIN;

ADULT; ALLOIMMUNITY; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; FEMALE; HEMOGLOBIN SC DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; PRIORITY JOURNAL; SERODIAGNOSIS; SICKLE CELL ANEMIA;

EID: 0030657570     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.6.658     Document Type: Article

References (24)

1. Brecher ME. Hemolytic transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:747-764.
2. Lee S, Wu X, Reid M, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood. 1995;85:912-916.
3. Lee S, Zambas E, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood. 1995;85:1364-1370.
4. Ramsey G, Smietana SJ. Long-term follow-up testing of red cell alloantibodies. Transfusion. 1994;34:122-124.
5. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol. 1992;79:239-244.
6. Giblett ER. Js, a 'new' blood group antigen found in Negroes. Nature. 1958;181:1221-1222.
7. a, a 'new' red-cell antigen found in Negroes: evidence for an eleventh blood group system. Br J Haematol. 1959;5:319-326.
8. a. Transfusion. 1962;2:423-424.
9. a. Transfusion. 1965;5:359.
10. a. Transfusion. 1973;13:153.
11. a. Transfusion. 1980;20:714-715.
12. a (K6) in a Japanese female. Vox Sang. 1979;37:350-351.
13. Taddie SJ, Barrasso C, Ness PM. A delayed transfusion reaction calised by anti-K6. Transfusion. 1982;22:68-69.
14. Reid CD, Charache S, Lubin B, eds. Management and Therapy of Sickle Cell Disease. 3rd ed. Bethesda, Md: National Institutes of Health, 1995. NIH publication No. 95-2117.
15. Vengelan-Tyler V, ed. Technical Manual. 12th ed. Bethesda, Md: American Association of Blood Banks; 1996.
16. Ness PM, Shirley RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion. 1990;30:688-693.
17. Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol. 1978;5:101-106.
18. Ambruso DR, Githens R, Alcorn DJ, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94-98.
19. Vichinsky EP, Earles A, Johnson RA, Hoag S, Williams A, Luban B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New Engl J Med. 1990;322:1617-1621.
20. Sosler SD, July BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol. 1993;43:103-106.
21. Lee S, Wu X, Reid M, Redman C. Molecular basis of the K:6,-7[Js(a+b-)] phenotype in the Kell blood group system. Transfusion. 1995;35:822-825.
22. Lin CK, Wong KF, Mak KH, Yuen CM, Lee, AW. Hemolytic transfusion reaction due to Rh antibodies detectable only by manual polybrene and polyethylene glycol technique. Am J Clin Pathol. 1995;104:660-662.
23. Issitt, PD, Combs, MR, Bredehoeft, SJ, et al. Lack of clinical significance of 'enzyme-only' red cell alloantibodies. Transfusion. 1993;33:284-293.
24. Shirey RS, Boyd JS, Ness PM. Polyethylene glycol versus low-ionic-strength solution in pretransfusion testing: a blinded comparison study. Transfusion. 1994;34:368-370.